| |
|
|
|
Aerpio Pharmaceuticals Inc  
|
|
1.27 -0.04 (-0.03%) |
01-22 16:00 |
|
Open: |
1.29 |
Pre close: |
1.31 |
Target:
|
1.62
|
|
High: |
1.32 |
Low: |
1.26 |
Resistance:
|
1.39
1.62
|
|
Volume: |
1,383,087 |
Market Cap: |
60M |
Support:
|
1.12
0.96
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.28
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
1.13 |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
1.38  |
Stochastic Oscillator |
%K(14,3):
|
82.06 |
|
MA(250): |
1.12 |
%D(3): |
87.06 |
|
Average Volume(K) |
3-Month: |
240210
|
52-Week |
High:
|
2.31 |
|
10-Days: |
196901 |
Low: |
0.42 |
|
RSI |
RSI(14):
|
52.02 |
Change(%): |
95.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.102 |
Return on Equity (ttm) |
-9.1 |
Shares Out. (M) |
47.11 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-5.8 |
Shares Float (M) |
30.95 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
16.18 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
41.53 |
|
Forward EPS |
-0.310 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
615 |
|
Book Value (p.s.) |
1.000 |
EBITDA (p.s.) |
-0.092 |
P/E |
-12.45 |
|
Sales Per Share |
0.318 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.27 |
|
Profit Margin |
-26.96 |
Operating Cash Flow
(M) |
-5.43 |
P/S |
3.99 |
|
Operating Margin |
-29.27 |
Levered Free Cash Flow
(M) |
-4.39 |
P/CF |
-11.02 |
|
|
|
|
|
|
